...
首页> 外文期刊>International Journal of Pharmaceutics >Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination
【24h】

Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination

机译:通过热熔挤出连续生产基于伊曲康唑的固体分散体:预配制,优化和设计空间确定

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this work was to increase the solubility and the dissolution rate of itraconazole, which was chosen as the model drug, by obtaining an amorphous solid dispersion by hot melt extrusion. Therefore, an initial preformulation study was conducted using differential scanning calorimetry, thermogravimetric analysis and Hansen's solubility parameters in order to find polymers which would have the ability to form amorphous solid dispersions with itraconazole. Afterwards, the four polymers namely Kollidon (R) VA64, Kollidon (R) 12PF, Affinisol (R) HPMC and Soluplus (R), that met the set criteria were used in hot melt extrusion along with 25 wt.% of itraconazole. Differential scanning confirmed that all four polymers were able to amorphize itraconazole. A stability study was then conducted in order to see which polymer would keep itraconazole amorphous as long as possible. Soluplus (R) was chosen and, the formulation was fine-tuned by adding some excipients (AcDiSol (R), sodium bicarbonate and poloxamer) during the hot melt extrusion process in order to increase the release rate of itraconazole. In parallel, the range limits of the hot melt extrusion process parameters were determined. A design of experiment was performed within the previously defined ranges in order to optimize simultaneously the formulation and the process parameters. The optimal formulation was the one containing 2.5 wt.% of AcDiSol (R) produced at 155 degrees C and 100 rpm. When tested with a biphasic dissolution test, more than 80% of itraconazole was released in the organic phase after 8 h. Moreover, this formulation showed the desired thermoformability value. From these results, the design space around the optimum was determined. It corresponds to the limits within which the process would give the optimized product. It was observed that a temperature between 155 and 170 degrees C allowed a high flexibility on the screw speed, from about 75 to 130 rpm. (C) 2016 Elsevier B.V. All rights reserved.
机译:这项工作的目的是通过热熔挤出获得无定形固体分散体,从而提高被选作模型药物的伊曲康唑的溶解度和溶解速率。因此,使用差示扫描量热法,热重分析法和汉森的溶解度参数进行了初步的预配制研究,以发现能够与伊曲康唑形成非晶态固体分散体的聚合物。然后,将符合设定标准的四种聚合物即Kollidon VA64,Kollidon 12PF,Affinisol HPMC和Soluplus与25 wt。%的伊曲康唑一起用于热熔挤出。差示扫描证实所有四种聚合物均能够使伊曲康唑非晶化。然后进行稳定性研究,以观察哪种聚合物会尽可能长时间保持伊曲康唑无定形。选择Soluplus(R),并在热熔挤出过程中通过添加一些赋形剂(AcDiSol(R),碳酸氢钠和泊洛沙姆)对配方进行微调,以提高伊曲康唑的释放速率。同时,确定了热熔挤出工艺参数的范围极限。为了同时优化配方和工艺参数,在预先定义的范围内进行了实验设计。最佳配方是在155摄氏度和100 rpm下生产的含有2.5 wt。%AcDiSol(R)的配方。用双相溶出度测试进行测试时,8小时后,有机相中释放出超过80%的伊曲康唑。此外,该配方显示出所需的热成型性值。根据这些结果,确定了最佳方案周围的设计空间。它对应于过程将给出优化产品的限制。观察到,在155至170℃之间的温度允许螺杆速度具有高的挠性,从约75至130rpm。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号